RZLT - Rezolute Inc logo

RZLT

Rezolute Inc

Rev โ€”top 1%10Y
Hold

Rezolute, Inc. develops therapies for rare metabolic diseases, focusing on hypoglycemia caused by hyperinsulinism. Its lead asset, ersodetug, is a human monoclonal antibody in Phase 3 trials for congenital hyperinsulinism and tumor hyperinsulinism.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$96today

Score Overview

1 Year
Scoreโ€”
Net Growth-9.51%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-289.84%
Net TrendNever
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-445.58%
Net Trend10%
Net Income Consistency
Rev Growthโ€”
Rev Trend10%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-1651x
Net Trend7%
Net Income Consistency
Rev Growthโ€”
Rev Trend8%
Revenue Consistency

See the full market ranking โ†’

Rezolute Inc fundamental performance

Across Rezolute Inc's full reported history, from 2012 to 2025, net income went from -$ 49.29K to -$ 74M. Revenue increased in 8% of the years measured; net income in 7%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.70โ€”
1 Year2025-08-12
$ 6.20-24.19%
5 Years2021-08-12
$ 11.06-57.50%
10 Years2016-08-12
$ 49.00-90.41%
All Time2014-05-01
$ 200.00-97.65%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 46K-$ 81M$ 120M
2025$ 0.00-$ 74M$ 167M
2024$ 0.00-$ 68M$ 126M
2023$ 0.00-$ 51M$ 101M
2022$ 0.00-$ 41M$ 150M
2021$ 0.00-$ 20M$ 41M
2020$ 0.00-$ 20M$ 9M
2019$ 0.00-$ 30M$ 11M
2018$ 0.00-$ 29M$ 1M
2017$ 0.00-$ 20M$ 4M
2016$ 0.00-$ 14M$ 4M
2015$ 0.00-$ 11M$ 5M
IPO2014$ 0.00-$ 9M$ 5M
2013-$ 6M$ 527.00
2012-$ 49.29K$ 25.88K

Explore beyond RZLT

You're looking at Rezolute Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies